MarketCap
Facebook
X
Telegram
Harrow Health P/B Ratio | HROW
Annual P/B Ratio Harrow Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.1 | 27.1 | 4.93 | 17.6 | 18.9 | 8.69 | 5.94 | 5.31 | 14.7 | 4.68 | -41.2 | 8.26 | 4.7 | 3.71 | -0.842 | -614 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 37.1 | -614 | -30.9 |
P/B Ratio of other stocks in the Drug manufacturers industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ProPhase Labs
PRPH
|
2.05 | - | - | $ 5.07 M |  USA |
 |
Endo International plc
ENDP
|
0.0133 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
-0.0724 | - | - | $ 36.6 M | USA |
 |
HEXO Corp.
HEXO
|
0.88 | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
0.687 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
2.78 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
0.703 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-27.6 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
-18.8 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
-0.0793 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
2.2 | - | - | $ 142 M | USA |
 |
OrganiGram Holdings
OGI
|
0.492 | $ 0.93 | 1.64 % | $ 88.6 M | Canada |
 |
Athenex
ATNX
|
-0.473 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
9.71 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
3.01 | - | - | $ 11.5 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
0.599 | $ 1.14 | -1.72 % | $ 1.92 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.46 | - | -39.89 % | $ 27.7 M | USA |
 |
Cronos Group
CRON
|
0.644 | $ 2.81 | 2.55 % | $ 1.08 B | Canada |
 |
TherapeuticsMD
TXMD
|
0.857 | $ 2.06 | - | $ 23.8 M | USA |
 |
Jupiter Wellness
JUPW
|
-1.09 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
-0.0916 | - | 1.15 % | $ 7.11 M | USA |
 |
Canopy Growth Corporation
CGC
|
0.419 | $ 0.89 | -1.82 % | $ 265 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
3.46 | $ 6.61 | -5.37 % | $ 98.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
0.00923 | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
0.802 | - | - | $ 150 M | USA |
 |
Radius Health
RDUS
|
-1.56 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
456 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
2.27 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
-0.148 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
2.31 | - | -27.8 % | $ 2.56 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
0.406 | - | - | $ 55.5 M | USA |
 |
Zomedica Corp.
ZOM
|
0.572 | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
1.87 K | - | - | $ 3.25 M | USA |
 |
Perrigo Company plc
PRGO
|
0.668 | $ 10.09 | -0.1 % | $ 1.4 B | USA |
 |
Bausch Health Companies
BHC
|
5.38 | $ 4.43 | -0.45 % | $ 1.64 B | Canada |
 |
Emergent BioSolutions
EBS
|
0.865 | $ 7.26 | -3.2 % | $ 388 M | USA |
 |
China Pharma Holdings
CPHI
|
0.121 | $ 1.52 | -18.28 % | $ 6.52 M |  China |
 |
Aurora Cannabis
ACB
|
0.368 | $ 2.67 | -0.74 % | $ 146 M | Canada |
 |
SCYNEXIS
SCYX
|
0.769 | $ 3.73 | -5.81 % | $ 186 M | USA |
 |
Evolus
EOLS
|
-11.7 | $ 5.98 | -0.17 % | $ 386 M | USA |
 |
Rockwell Medical
RMTI
|
0.914 | $ 6.63 | 1.61 % | $ 239 M | USA |
 |
Solid Biosciences
SLDB
|
3.46 | $ 7.83 | -1.88 % | $ 685 M | USA |
 |
Relmada Therapeutics
RLMD
|
2.85 | $ 5.18 | -0.38 % | $ 205 M | USA |
 |
Veru
VERU
|
4.63 | $ 2.25 | -2.6 % | $ 33 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.777 | $ 2.39 | -1.65 % | $ 303 M | USA |
 |
Pacira BioSciences
PCRX
|
1.51 | $ 25.88 | -0.19 % | $ 1.2 B | USA |
 |
Sundial Growers
SNDL
|
0.316 | $ 1.25 | -0.4 % | $ 323 M | Canada |
 |
cbdMD
YCBD
|
0.495 | $ 0.54 | -6.6 % | $ 2.17 M | USA |
 |
Tilray
TLRY
|
0.358 | $ 3.88 | -2.76 % | $ 2.4 B | Canada |